The importance of platelet testing
While it is not a regulatory requirement to test the effect of all drugs on platelets, platelet testing can be an important stage of the drug discovery process that will help companies understand the possible effects of their compounds in development on platelets and de-risk further development process. The purpose of platelet testing There are […]
Natalia Dovlatova’s career journey
Recently we sat down with Platelet Services CEO Natalia Dovlatova to discuss her career journey and plans for the future of the company. Before Platelet Services Natalia has always been drawn to platelet research, and it was the focus of her dissertation when completing her medical degree in Moscow. During her degree she was introduced […]
Platelet research continues to flourish!
Towards the end of April, four of the Platelet Services team were delighted to travel to Aberdeen for the annual Platelet Society meeting. This group of platelet focused researchers from academic and industrial based laboratories have been meeting annually, sometimes as part of a larger European conference, since 1998. On this occasion, around 90 scientists, […]
Oral antiplatelet therapy – half a century of evolution
It is now 50 years since the first randomised, controlled trial of aspirin in the secondary prevention of mortality from myocardial infarction (MI)[1]. Although the results of the trial were statistically inconclusive, positive signals were observed. Over the next two decades, multiple studies were conducted in a range of patient groups leading to the conclusion […]
Celebrating our fifth anniversary
Recently we celebrated five years as Platelet Services and in this blog we are looking back on some of our highlights over the last five years and our plans for the future. Our history We began the company in 2018 with 4 part-time consultants and now are a talented team of 7. We have worked […]
American College of Toxicology (ACT) 44th Annual Meeting: post event round-up
Platelet Services’ Natalia Dovlatova and Charlotte Jewell recently spent several days in Orlando, Florida while attending the American College of Toxicology (ACT) 44th Annual Meeting which took place at the Rosen Shingle Creek Hotel and brings together a community of scientists from pharmaceutical and biotech industries, regulatory agencies, CROs, academia, and R&D consultants. Key highlights […]
Therapeutic antibodies can have an effect on platelet function
Monoclonal antibodies (mAbs) are being discovered and developed as new therapeutic approaches to combat different diseases such as cancers, autoimmune diseases, HIV and more. Some immunoglobulin G (IgG) mAbs have been shown to affect platelet function with risk of thrombotic or bleeding side effects occurring in patients. They can induce platelet activation by different mechanisms […]
Meet the team: Dr Paul Cato
Senior Research Scientist, Paul Cato, started out his career in haematology and shares the career journey that led him back to working with platelets here at Platelet Services. Always interested in science, Paul went to the University of the West of England (UWE) in Bristol to study biology. It was while he was studying towards […]
Andrew Johnson: Celebrating 40 years in science
Andrew Johnson is the Laboratory Manager at Platelet Services and this year, he celebrates 40 years working in science. In our latest blog, Andrew shares his career journey that led him to Platelet Services. From an early age, Andrew was always interested in science. At school he took CSEs but knew he needed to get […]
EUPLAN International Conference: post event round-up
Platelet Services’ Charlotte Jewell and Paul Cato recently jetted off on an exciting trip to Milan, Italy to attend the EUPLAN International Conference. It took place at the beautiful University of Milan, which possesses important artistic and cultural heritage dating back to the 15th Century. Charlotte and Paul were delighted to join fellow scientists from […]
